Guobang Pharma Ltd. (SHA:605507)
China · Delayed Price · Currency is CNY 20.86
+0.01 (0.05%)
Jul 18, 2025, 3:00 PM CST
Guobang Pharma Market Cap
Guobang Pharma has a market cap or net worth of 11.64 billion as of July 18, 2025. Its market cap has increased by 22.56% in one year.
Market Cap
11.64B
Enterprise Value
10.37B
Revenue
5.99B
Ranking
n/a
PE Ratio
14.68
Stock Price
20.86
Market Cap Chart
Since August 2, 2021, Guobang Pharma's market cap has decreased from 26.21B to 11.64B, a decrease of -55.58%. That is a compound annual growth rate of -18.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 11.64B | 1.12% |
| Dec 31, 2024 | 11.51B | 17.32% |
| Dec 29, 2023 | 9.81B | -33.66% |
| Dec 30, 2022 | 14.79B | -8.19% |
| Dec 31, 2021 | 16.11B | -38.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 381.35B |
| Shenzhen Mindray Bio-Medical Electronics | 259.60B |
| WuXi AppTec | 225.41B |
| Zhangzhou Pientzehuang Pharmaceutical., | 119.06B |
| Sichuan Biokin Pharmaceutical | 117.85B |
| Aier Eye Hospital Group | 114.24B |
| Shanghai United Imaging Healthcare | 102.75B |
| Yunnan Baiyao Group Co.,Ltd | 99.76B |